4//SEC Filing
Zaks Tal Zvi 4
Accession 0001127602-21-020699
CIK 0001682852other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 5:22 PM ET
Size
8.3 KB
Accession
0001127602-21-020699
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Zaks Tal Zvi
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-06-23−5,000→ 126,120 totalExercise: $25.93Exp: 2030-02-28→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2021-06-23$25.93/sh+5,000$129,650→ 5,000 total - Sale
Common Stock
2021-06-23$219.65/sh−5,000$1,098,250→ 0 total
Footnotes (2)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021.
- [F2]25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001690927
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 5:22 PM ET
- Size
- 8.3 KB